Document
IPR2016-00297, No. 2047-23 Exhibit - Poster P681 (P.T.A.B. Sep. 14, 2016)
Cite Document
IPR2016-00297, No. 2047-23 Exhibit - Poster P681 (P.T.A.B. Sep. 14, 2016)
+ More Snippets
Document
IPR2016-00297, No. 2036-12 Exhibit - Johnson Declaration (P.T.A.B. Sep. 14, 2016)
Cite Document
IPR2016-00297, No. 2036-12 Exhibit - Johnson Declaration (P.T.A.B. Sep. 14, 2016)
+ More Snippets
Document
IPR2016-00297, No. 2010 Exhibit - Hanauer 2004 (P.T.A.B. Mar. 15, 2016)
Cite Document
IPR2016-00297, No. 2010 Exhibit - Hanauer 2004 (P.T.A.B. Mar. 15, 2016)
+ More Snippets
Document
IPR2016-00297, No. 1001-2 Exhibit - US Patent No 8,865,688 (P.T.A.B. Dec. 15, 2015)
Cite Document
IPR2016-00297, No. 1001-2 Exhibit - US Patent No 8,865,688 (P.T.A.B. Dec. 15, 2015)
+ More Snippets
Document
IPR2016-00297, No. 1020-2 Exhibit - 688 Patent File History, Amendment 1082013 (P.T.A.B. Dec. 15, 2015)
Cite Document
IPR2016-00297, No. 1020-2 Exhibit - 688 Patent File History, Amendment 1082013 (P.T.A.B. Dec. 15, 2015)
+ More Snippets
Document
IPR2016-00297, No. 1026 Exhibit - Brouwers, JRBJ, Advanced and controlled drug delivery systems in clinical disease management, Pharmacy World and Science (P.T.A.B. Dec. 8, 2015)
Cite Document
IPR2016-00297, No. 1026 Exhibit - Brouwers, JRBJ, Advanced and controlled drug delivery systems in clinical disease management, Pharmacy World and Science (P.T.A.B. Dec. 8, 2015)
+ More Snippets
Document
IPR2016-00297, No. 1004 Exhibit - Stephen Hanauer et al, Mesalamine Capsules for Treatment of Active Ulcerative Colitis, results of A Controlled Trial, 88 AMERICAN J GASTROENTEROLOGY...
Cite Document
IPR2016-00297, No. 1004 Exhibit - Stephen Hanauer et al, Mesalamine Capsules for Treatment of Active Ulcerative Colitis, results of A Controlled Trial, 88 AMERICAN J GASTROENTEROLOGY 1188 (P.T.A.B. De
+ More Snippets
Document
IPR2016-00297, No. 1006 Exhibit - L M L Stolk et al, Dissolution Profiles of Mesalazine Formulation in Vitro, 12 PHARMACEUTISCH WEEKBLAD SCIENTIFIC EDITION 200 (P.T.A.B. Dec. 8, 2015...
Cite Document
IPR2016-00297, No. 1006 Exhibit - L M L Stolk et al, Dissolution Profiles of Mesalazine Formulation in Vitro, 12 PHARMACEUTISCH WEEKBLAD SCIENTIFIC EDITION 200 (P.T.A.B. Dec. 8, 2015)
+ More Snippets
Document
IPR2016-00297, No. 2027-5 Exhibit - MPUC3003 (P.T.A.B. Jul. 22, 2016)
Cite Document
IPR2016-00297, No. 2027-5 Exhibit - MPUC3003 (P.T.A.B. Jul. 22, 2016)
+ More Snippets
Document
IPR2016-00297, No. 2031 Exhibit - Sinha 2003 (P.T.A.B. Mar. 15, 2016)
Cite Document
IPR2016-00297, No. 2031 Exhibit - Sinha 2003 (P.T.A.B. Mar. 15, 2016)
+ More Snippets
Document
IPR2016-00297, No. 1001 Exhibit - US Patent No 8,865,688 (P.T.A.B. Dec. 8, 2015)
Cite Document
IPR2016-00297, No. 1001 Exhibit - US Patent No 8,865,688 (P.T.A.B. Dec. 8, 2015)
+ More Snippets
Document
IPR2016-00297, No. 2051-43 Exhibit - US Patent Application Publication No 20070167416 (P.T.A.B. Jan. 3, 2017)
Cite Document
IPR2016-00297, No. 2051-43 Exhibit - US Patent Application Publication No 20070167416 (P.T.A.B. Jan. 3, 2017)
+ More Snippets
Document
IPR2016-00297, No. 1067-40 Exhibit - Ex 1067 (P.T.A.B. Dec. 23, 2016)
Cite Document
IPR2016-00297, No. 1067-40 Exhibit - Ex 1067 (P.T.A.B. Dec. 23, 2016)
+ More Snippets
Document
IPR2016-00297, No. 2035-11 Exhibit - Safdi Declaration (P.T.A.B. Sep. 14, 2016)
Cite Document
IPR2016-00297, No. 2035-11 Exhibit - Safdi Declaration (P.T.A.B. Sep. 14, 2016)
+ More Snippets
Document
IPR2016-00297, No. 2001 Exhibit - 2009 Asacol PDR (P.T.A.B. Mar. 15, 2016)
Cite Document
IPR2016-00297, No. 2001 Exhibit - 2009 Asacol PDR (P.T.A.B. Mar. 15, 2016)
+ More Snippets